Emahnuel Troisi Lopez

Dr. Emahnuel Troisi Lopez

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 July 2021 in eLife
Verified
Journal Article
Open access
PSPierpaolo Sorrentino
Pierpaolo Sorrentino
CSCaio Seguin
Caio Seguin
RRRosaria Rucco
Rosaria Rucco
MLMarianna Liparoti
Marianna Liparoti
ELEmahnuel Troisi Lopez
Emahnuel Troisi Lopez
AZAndrew Zalesky
Andrew Zalesky
Brain activity during rest displays complex, rapidly evolving patterns in space and time. Structural connections comprising the human connectome are hypothesized to impose constraints on the dynamics of this activity. Here, we use magnetoencephalography (MEG) to quantify the extent to which fast neural dynamics in the human brain are constrained by structural connections inferred from diffusion MRI tractography. We characterize the spatio-temporal unfolding of whole-brain activity at the millisecond scale from source-reconstructed MEG data, estimating the probability that any two brain regions will significantly deviate from baseline activity in consecutive time epochs. We find that the structural connectome relates to, and likely affects, the rapid spreading of neuronal avalanches, evidenced by a significant association between these transition probabilities and structural connectivity strengths (r = 0.37, p<0.0001). This finding opens new avenues to study the relationship between brain structure and neural dynamics.

22 November 2022 in Neurology
Verified
Journal Article
Open access
PDF file
APArianna Polverino
Arianna Polverino
ELEmahnuel Troisi Lopez
Emahnuel Troisi Lopez
RMRoberta Minino
Roberta Minino
MLMarianna Liparoti
Marianna Liparoti
ARAntonella Romano
Antonella Romano
PSPierpaolo Sorrentino
Pierpaolo Sorrentino
Background and Objectives Amyotrophic lateral sclerosis (ALS) is a multisystem disorder, as supported by clinical, molecular, and neuroimaging evidence. As a consequence, predicting clinical features requires a description of large-scale neuronal dynamics. Normally, brain activity dynamically reconfigures over time, recruiting different brain areas. Brain pathologies induce stereotyped dynamics which, in turn, are linked to clinical impairment. Hence, based on recent evidence showing that brain functional networks become hyperconnected as ALS progresses, we hypothesized that the loss of flexible dynamics in ALS would predict the symptoms severity. Methods To test this hypothesis, we quantified flexibility using the “functional repertoire” (i.e., the number of configurations of active brain areas) as measured from source-reconstructed magnetoencephalography (MEG) in patients with ALS and healthy controls. The activity of brain areas was reconstructed in the classic frequency bands, and the functional repertoire was estimated to quantify spatiotemporal fluctuations of brain activity. Finally, we built a k-fold cross-validated multilinear model to predict the individual clinical impairment from the size of the functional repertoire. Results Comparing 42 patients with ALS and 42 healthy controls, we found a more stereotyped brain dynamics in patients with ALS (p < 0.05), as conveyed by the smaller functional repertoire. The relationship between the size of the functional repertoire and the clinical scores in the ALS group showed significant correlations in both the delta and the theta frequency bands. Furthermore, through a k-fold cross-validated multilinear regression model, we found that the functional repertoire predicted both clinical staging (p < 0.001 and p < 0.01, in the delta and theta bands, respectively) and symptoms severity (p < 0.001, in both the delta and theta bands). Discussion Our work shows that (1) ALS pathology reduces the flexibility of large-scale brain dynamics, (2) subcortical regions play a key role in determining brain dynamics, and (3) reduced brain flexibility predicts disease stage and symptoms severity. Our approach provides a noninvasive tool to quantify alterations in brain dynamics in ALS (and, possibly, other neurodegenerative diseases), thus opening new opportunities in disease management and a framework to test, in the near future, the effects of disease-modifying interventions at the whole-brain level.

22 November 2022 in Human Brain Mapping
Verified
Journal Article
Open access
ELEmahnuel Troisi Lopez
Emahnuel Troisi Lopez
RMRoberta Minino
Roberta Minino
MLMarianna Liparoti
Marianna Liparoti
APArianna Polverino
Arianna Polverino
ARAntonella Romano
Antonella Romano
PSPierpaolo Sorrentino
Pierpaolo Sorrentino
The clinical connectome fingerprint (CCF) was recently introduced as a way to assess brain dynamics. It is an approach able to recognize individuals, based on the brain network. It showed its applicability providing network features used to predict the cognitive decline in preclinical Alzheimer's disease. In this article, we explore the performance of CCF in 47 Parkinson's disease (PD) patients and 47 healthy controls, under the hypothesis that patients would show reduced identifiability as compared to controls, and that such reduction could be used to predict motor impairment. We used source‐reconstructed magnetoencephalography signals to build two functional connectomes for 47 patients with PD and 47 healthy controls. Then, exploiting the two connectomes per individual, we investigated the identifiability characteristics of each subject in each group. We observed reduced identifiability in patients compared to healthy individuals in the beta band. Furthermore, we found that the reduction in identifiability was proportional to the motor impairment, assessed through the Unified Parkinson's Disease Rating Scale, and, interestingly, able to predict it (at the subject level), through a cross‐validated regression model. Along with previous evidence, this article shows that CCF captures disrupted dynamics in neurodegenerative diseases and is particularly effective in predicting motor clinical impairment in PD.

10 June 2021 in Journal of Neuroscience Research
Verified
Journal Article
Open access
PDF file
MLMarianna Liparoti
Marianna Liparoti
ELEmahnuel Troisi Lopez
Emahnuel Troisi Lopez
LSLaura Sarno
Laura Sarno
RRRosaria Rucco
Rosaria Rucco
RMRoberta Minino
Roberta Minino
PSPierpaolo Sorrentino
Pierpaolo Sorrentino
The menstrual cycle (MC) is a sex hormone‐related phenomenon that repeats itself cyclically during the woman's reproductive life. In this explorative study, we hypothesized that coordinated variations of multiple sex hormones may affect the large‐scale organization of the brain functional network and that, in turn, such changes might have psychological correlates, even in the absence of overt clinical signs of anxiety and/or depression. To test our hypothesis, we investigated longitudinally, across the MC, the relationship between the sex hormones and both brain network and psychological changes. We enrolled 24 naturally cycling women and, at the early‐follicular, peri‐ovulatory, and mid‐luteal phases of the MC, we performed: (a) sex hormone dosage, (b) magnetoencephalography recording to study the brain network topology, and (c) psychological questionnaires to quantify anxiety, depression, self‐esteem, and well‐being. We showed that during the peri‐ovulatory phase, in the alpha band, the leaf fraction and the tree hierarchy of the brain network were reduced, while the betweenness centrality (BC) of the right posterior cingulate gyrus (rPCG) was increased. Furthermore, the increase in BC was predicted by estradiol levels. Moreover, during the luteal phase, the variation of estradiol correlated positively with the variations of both the topological change and environmental mastery dimension of the well‐being test, which, in turn, was related to the increase in the BC of rPCG. Our results highlight the effects of sex hormones on the large‐scale brain network organization as well as on their possible relationship with the psychological state across the MC. Moreover, the fact that physiological changes in the brain topology occur throughout the MC has widespread implications for neuroimaging studies.

1 June 2022 in Brain Connectivity
Verified
Journal Article
Closed access
RRRosaria Rucco
Rosaria Rucco
ALanna lardone
anna lardone
MLMarianna Liparoti
Marianna Liparoti
ELEmahnuel Troisi Lopez
Emahnuel Troisi Lopez
RMRosa De Micco
Rosa De Micco
PSPierpaolo Sorrentino
Pierpaolo Sorrentino
Aim The aim of the present study is to investigate the relations between both functional connectivity and brain networks with cognitive decline, in patients with Parkinson’s disease (PD). Introduction PD phenotype is not limited to motor impairment but, rather, a wide range of non-motor disturbances can occur, cognitive impairment being one of the commonest. However, how the large-scale organization of brain activity differs in cognitively impaired patients, as opposed to cognitively preserved ones, remains poorly understood. Methods Starting from source-reconstructed resting-state magnetoencephalography data, we applied the PLM to estimate functional connectivity, globally and between brain areas, in PD patients with and without cognitive impairment (respectively PD-CI and PD-NC), as compared to healthy subjects (HS). Furthermore, using graph analysis, we characterized the alterations in brain network topology and related these, as well as the functional connectivity, to cognitive performance. Results We found reduced global and nodal PLM in several temporal (fusiform gyrus, Heschl's gyrus and inferior temporal gyrus), parietal (postcentral gyrus), and occipital (lingual gyrus) areas within the left hemisphere, in the gamma band, in PD-CI patients, as compared to PD-NC and HS. With regard to the global topological features, PD-CI patients, as compared to HS and PD-NC patients, showed differences in multi frequencies bands (delta, alpha, gamma) in the Leaf fraction, Tree hierarchy (both higher in PD-CI) and Diameter (lower in PD-CI). Finally, we found statistically significant correlations between the MoCA test and both the Diameter in delta band and the Tree Hierarchy in the alpha band. Conclusion Our work points to specific large-scale rearrangements that occur selectively in cognitively compromised PD patients and correlated to cognitive impairment.

23 June 2022 in NeuroImage: Clinical
Verified
Journal Article
Open access
ARAntonella Romano
Antonella Romano
ELEmahnuel Troisi Lopez
Emahnuel Troisi Lopez
MLMarianna Liparoti
Marianna Liparoti
APArianna Polverino
Arianna Polverino
RMRoberta Minino
Roberta Minino
PSPierpaolo Sorrentino
Pierpaolo Sorrentino
• The Clinical Connectome Fingerprint (CCF) is an approach able to determine subject-specific connectivity features in a given population. • Patients with Amyotrophic lateral sclerosis (ALS) show reduced identifiability compared to healthy controls. • The I-clinical is a measure of subject-specific clinical identification and predict both the motor impairment and the disease progression in ALS patients. • The predictive power of the clinical fingerprint may represent a promising tool in ALS clinical management.